TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Clinical trial NCT07246304 · RECRUITING

Trial details

NCT number: NCT07246304
Sponsor: TCRCure Biopharma Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer ( SCLC )CAR-T Cell Therapy

Start date: 2025-11-30
Primary completion: 2027-11-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.